Lisa Von Moltke

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double‐blind, placebo‐controlled, randomized, proof‐of‐concept study

Clarissa E. Vergunst, Daniëlle M. Gerlag, Lisa Von Moltke et al. · Arthritis & Rheumatism · 2009 · 79 citations

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent <i>Clostridioides difficile</i> Infection

Matthew Sims, Sahil Khanna, Paul Feuerstadt et al. · JAMA Network Open · 2023 · 74 citations · Full text

Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study

Karthik Venkatakrishnan, Michael Rader, Ramesh K. Ramanathan et al. · Clinical Therapeutics · 2009 · 62 citations

Oncology, Medicine, Metronomic Therapy +8

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model

Marjie Hard, Richard J. Mills, Brian M. Sadler et al. · CNS Drugs · 2017 · 42 citations · Full text

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

Ticiana B. Leal, Scot C. Remick, Chris H. Takimoto et al. · Cancer Chemotherapy and Pharmacology · 2011 · 41 citations · Full text

Urology, Oncology, Impaired Renal Function +10